Parnassus Investments’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Buy |
15,981
+917
| +6% | +$98.5K | ﹤0.01% | 130 |
|
|
2025
Q1 | $1.52M | Buy |
15,064
+203
| +1% | +$20.5K | ﹤0.01% | 128 |
|
|
2024
Q4 | $1.33M | Buy |
14,861
+97
| +0.7% | +$8.66K | ﹤0.01% | 118 |
|
|
2024
Q3 | $1.24M | Buy |
14,764
+1,284
| +10% | +$108K | ﹤0.01% | 117 |
|
|
2024
Q2 | $1.04M | Buy |
13,480
+2,021
| +18% | +$156K | ﹤0.01% | 120 |
|
|
2024
Q1 | $785K | Buy |
11,459
+1,748
| +18% | +$120K | ﹤0.01% | 128 |
|
|
2023
Q4 | $561K | Buy |
9,711
+2,038
| +27% | +$118K | ﹤0.01% | 122 |
|
|
2023
Q3 | $405K | Buy |
7,673
+244
| +3% | +$12.9K | ﹤0.01% | 129 |
|
|
2023
Q2 | $402K | Sell |
7,429
-644
| -8% | -$34.8K | ﹤0.01% | 123 |
|
|
2023
Q1 | $404K | Buy |
8,073
+2,916
| +57% | +$146K | ﹤0.01% | 121 |
|
|
2022
Q4 | $239K | Buy |
+5,157
| New | +$239K | ﹤0.01% | 131 |
|
|
2022
Q3 | – | Sell |
-15,691,959
| Closed | -$585M | – | 130 |
|
|
2022
Q2 | $585M | Sell |
15,691,959
-42,791
| -0.3% | -$1.59M | 1.4% | 27 |
|
|
2022
Q1 | $697M | Buy |
15,734,750
+194,219
| +1% | +$8.6M | 1.41% | 27 |
|
|
2021
Q4 | $660M | Sell |
15,540,531
-136,426
| -0.9% | -$5.8M | 1.27% | 31 |
|
|
2021
Q3 | $680M | Buy |
15,676,957
+564,197
| +4% | +$24.5M | 1.43% | 30 |
|
|
2021
Q2 | $646M | Buy |
15,112,760
+6,259,424
| +71% | +$268M | 1.41% | 29 |
|
|
2021
Q1 | $342M | Buy |
+8,853,336
| New | +$342M | 0.83% | 38 |
|